Liposome composition for improved intracellular delivery of a therapeutic agent

Details for Australian Patent Application No. 2002305094 (hide)

Owner Alza Corporation

Inventors Zalipsky, Samuel; Huang, Shi Kun; Allen, Theresa M.

Agent Shelston IP

Pub. Number AU-B-2002305094

PCT Number PCT/US02/09330

PCT Pub. Number WO2002/076428

Priority 60/278,869 26.03.01 US

Filing date 26 March 2002

Wipo publication date 8 October 2002

Acceptance publication date 11 January 2007

International Classifications

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 9/133 (2006.01) Medicinal preparations characterised by special physical form - Unilamellar vesicles

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/24 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen or sulfur

A61K 47/28 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Steroids

A61K 47/30 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/46 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Ingredients of undetermined constitution or reaction products thereof

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/278,869 26.03.01 US

27 March 2003 Application Open to Public Inspection

  Published as AU-B-2002305094

11 January 2007 Application Accepted

  Published as AU-B-2002305094

8 March 2007 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 09 Feb 2007. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

24 May 2007 Standard Patent Sealed

2 August 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 09 Feb 2007

22 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002305095-RAKE RECEIVER WITH EMBEDDED DECISION FEEDBACK EQUALIZER

2002305093-METHODS FOR DIAGNOSING AND TREATING MULTIPLE SCLEROSIS AND COMPOSITIONS THEREOF